Common Contracts
4 similar At-the-Market Sales Agreement contracts by Aridis Pharmaceuticals, Inc., ClearSign Technologies Corp, CohBar, Inc., Paratek Pharmaceuticals, Inc.
ARIDIS PHARMACEUTICALS, INC. Shares of Common Stock (par value $0.0001 per share) At-the-Market Sales AgreementAt-the-Market Sales Agreement • January 19th, 2022 • Aridis Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Aridis Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Virtu Americas LLC (the “Agent”), as follows:
CLEARSIGN TECHNOLOGIES CORPORATION Shares of Common Stock (par value $0.0001 per share) At-the-Market Sales AgreementAt-the-Market Sales Agreement • December 23rd, 2020 • ClearSign Technologies Corp • Industrial instruments for measurement, display, and control • New York
ClearSign Technologies Corporation, a Washington corporation (the “Company”), confirms its agreement (this “Agreement”) with Virtu Americas LLC (the “Agent”), as follows:
COHBAR, INC. Shares of Common Stock (par value $0.001 per share) At-the-Market Sales AgreementAt-the-Market Sales Agreement • May 27th, 2020 • CohBar, Inc. • Pharmaceutical preparations • New York
CohBar, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Virtu Americas LLC (the “Agent”), as follows:
AT THE MARKET SALES AGREEMENTAt the Market Sales Agreement • July 2nd, 2019 • Paratek Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Paratek Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Jefferies LLC and BTIG, LLC (each individually an “Agent” and collectively, the “Agents”) as follows:
